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Schizotypy phenotypes in the general population share etiopathogenicmechanisms and risk factors with schizophrenia, supporting
the notion of psychosis as a continuum ranging from nonclinical to clinical deviance. Catechol-O-methyltransferase (COMT) is a
candidate susceptibility gene for schizophrenia that is involved in the regulation of dopamine in the prefrontal cortex. Several recent
studies have reported a sex difference in the impact of COMT genotype on psychiatric and cognitive phenotypes and personality
traits. The present study investigated the association of COMT Val158Met (rs4680) with psychometric positive and negative
schizotypy and psychotic experiences in a sample of 808 nonclinical young adults. The main finding was that sex moderates the
association of COMT genotype with the negative dimension of both schizotypy and psychotic experiences. Male subjects carrying
theVal allele tended to score higher on the negative dimension of both trait and symptom-likemeasures.The results from the present
study are consistent with recent work suggesting an association between negative schizotypy and diminished prefrontal dopamine
availability. They support the idea that a biological differentiation underlies the positive and negative schizotypy dimensions.
Additionally, these findings contribute to the growing literature on sex-specific effects of COMTon the predisposition to psychiatric
disorders and personality traits.
1. Introduction
Functional, clinical, and genetic epidemiological studies
show that many parameters of brain function and structure
vary betweenmen andwomen [1]. Similarly, most psychiatric
disorders show sex differences in characteristics such as
incidence, age at onset, clinical features, and outcome [2].
These differences are usually ascribed to the influence of sex
hormones or the action of sex chromosome genes. However,
there is evidence that autosomal genes may contribute to
sex differences in the genetic predisposition to psychiatric
phenotypes [3]. Despite this, the identity of the contributing
genes is largely unknown. Several lines of evidence suggest
that the catechol-O-methyltransferase (COMT) gene, which
codes for an enzyme that plays an important role in the
cortical dopamine metabolism, may be one such gene. It
contains a functional polymorphism, a G>A substitution
(rs4680), which produces a valine-to-methionine (Val/Met)
substitution that influences COMT activity in the human
prefrontal cortex. Thus, dopamine signalling is likely to be
enhanced in Met carriers as compared to Val carriers. The
deficit and excess of dopamine have been related to posi-
tive and negative schizophrenia symptoms [4]. It has been
proposed that positive symptoms are due to a hyperactivity
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of subcortical dopamine transmission, while negative symp-
toms may be caused by a deficit in dopamine transmission,
particularly in the prefrontal cortex [5, 6]. However, the
precise mechanisms are still not well understood.
Several studies have reported a sex difference in the
impact of COMT genotype on psychiatric phenotypes and
personality traits (reviewed by Harrison and Tunbridge [7,
8]), but few have explored the hypothesis of an interaction
between sex and genotype [9, 10].
The association between schizophrenia and the high
activity Val allele has been analysed in several studies that
have culminated in different meta-analysis which showed
inconsistent results [11, 12]. The influence of sex on the
involvement of COMT genotype in schizophrenia vulnera-
bility has been reported in several studies [13–16]. Candidate
endophenotypes of schizophrenia, with which the disorder
presumably shares a degree of overlapping genetic liabil-
ity, include structural and morphometric brain alterations,
neurocognitive deficits, and schizotypal personality traits or
symptoms.
The underlying developmental vulnerability for schizo-
phrenia and spectrum disorders is expressed across a
dynamic continuum referred to as schizotypy or “psychosis
proneness” that ranges from subclinical to clinical manifesta-
tions [17–19]. Nonpsychotic schizotypes experience similar,
although attenuated, forms of the cognitive, emotional,
and behavioural disturbances inherent in schizophrenia
and are at heightened risk for developing schizophrenia-
spectrum disorders [20]. Like schizophrenia, schizotypy is
a multidimensional construct, positive and negative schizo-
typy dimensions being the most replicated factors [21].
According to family, twin and adoption studies [22] and
prior genome-wide scans of schizophrenia and schizotypy,
it seems that at least a subset of schizophrenia susceptibility
genes also affect schizotypy in nonpsychotic relatives [23].
The nonclinical psychosis phenotype is observed and
reliably measured at the level of schizotypy personality
features (using trait-like measures) and subclinical psychotic
experiences (PEs, i.e., unusual phenomena resembling clini-
cal psychotic experiences) (using symptom-basedmeasures).
These phenotypes seem to share etiopathogenic mechanisms
and risk factors with schizophrenia, thus supporting the
notion of psychosis as a continuum ranging from nonclinical
to clinical deviance [21, 24–28].
Evidence that the COMT Val158Met polymorphism may
indeed have an impact on schizotypal endophenotypes
was provided by Avramopoulos and colleagues [29]. They
reported that the high activity Val allele is associated with
self-reported schizotypy scores in a male population using
the Perceptual Aberration Scale and the total score of the
Schizotypal Personality Questionnaire. Further work showed
that the Val allele was specifically related to the negative
and disorganised dimensions of schizotypy [30, 31]. More
recently, two independent studies analysing subjects carrying
genetic liability for schizophrenia have found associations
between the high activity allele and positive and negative
schizotypy [32] and anhedonia (a central construct of neg-
ative schizotypy) [33]. To our knowledge, the association
between COMT variability and PEs has not been analysed
previously.
The present study aimed to explore (i) the association
between this functional polymorphism in the COMT gene
and dimensions of psychosis proneness using trait-like and
symptom-based measures and (ii) sex-specific effects of
the COMT on this phenotype in a sample of nonclini-
cal young adults. We hypothesised that the Val allele of
the Val158Met polymorphism, associated with diminished
prefrontal dopamine availability, would be associated with
higher scores on the negative dimension of both schizotypy
and PEs.
2. Materials and Methods
2.1. Participants. The sample comprised 808 subjects from
the general population, including 547 undergraduates
enrolled in psychology courses at the Universitat Auto`noma
de Barcelona (UAB) and 261 students from technical training
schools from Barcelona. Details of the two subsamples are
given in Table 1. The final sample comprised 184 men (23%)
and 624 women (77%). Males and females differed in terms
of age (males: mean = 21.4, SD = 4.5; females: mean = 20.6,
SD = 3.9, 𝑃 < 0.05). Ethical approval was obtained from local
research ethics committees. All participants volunteered
to take part in the study and provided written informed
consent. They were not preselected based upon any criteria.
2.2. Psychosis Proneness Assessment. All participants com-
pleted self-report measures assessing schizotypy and PEs.
Schizotypy was assessed with the Spanish version [34] of the
Wisconsin Schizotypy Scales (WSS), including the Percep-
tual Aberration [35], Magical Ideation [36], Revised Social
Anhedonia [37], and Physical Anhedonia [38] Scales. The
technical school volunteers completed the short version of
the scales [39]. Exploratory and confirmatory factor analyses
of the four scales reliably produce two factors, positive and
negative schizotypy, that account for 80% of the variance [21].
Although the raw scores on the four scales are not comparable
between the two samples, the factor structure underlying the
short scales is comparable with the factor structure of the
original scales (data not shown). Participants were assigned
positive and negative schizotypy factor scores based upon
factor loadings derived from a sample of 6137 college students
[21].
PEs were assessed with the Spanish version of the Com-
munity Assessment of Psychic Experiences (CAPE) [34, 40],
which evaluates three dimensions of symptoms: positive,
negative, and depressive (the depressive subscale was not
used in the present study). It has good validity and reliability
and has been used in general population studies [41].
2.3. Genotyping. Genomic DNA was extracted from buccal
mucosa on a cotton swab using the Real Extraction DNA
kit (Durviz S.L.U., Valencia, Spain). DNA quality from all
the samples was assessed by spectrophotometer readings
(A260/280) using Nanodrop.
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Table 1: Descriptive data for the undergraduate and technical training school students and comparison between the two subsamples.
Undergraduates Technical school
Age (mean (SD)) 20.60 (4.1) 21.20 (3.9) 𝑡 = −2.01 𝑃 = 0.045
Sex (men/women) 92/455 92/169 𝜒2 = 34.13 𝑃 = 0.000
COMT Val158Met (𝑛 (%))
Val/Val 151 (28.8%) 72 (28.5%)
Val/Met 253 (48.3%) 121 (47.8%) 𝜒2 = 0.064 𝑃 = 0.969
Met/Met 120 (22.9%) 60 (23.7%)
Schizotypy (WSS) (mean (SD))
Positive −0.55 (0.8) −0.26 (0.7) 𝑡 = −5.33 𝑃 = 0.000
Negative −0.18 (0.9) 0.24 (0.9) 𝑡 = −6.19 𝑃 = 0.000
Psychotic experiences (CAPE) (mean (SD))
Positive 7.24 (4.3) 9.72 (5.5) 𝑡 = −6.96 𝑃 = 0.000
Negative 8.92 (5.1) 9.62 (5.6) 𝑡 = −1.69 𝑃 = 0.092
WSS,Wisconsin Schizotypy Scales; CAPE, Community Assessment of Psychic Experiences. Differences were considered significant if𝑃was below 0.05 (shown
in bold).
Table 2: Descriptive data and ANCOVA statistics for the twoWSS factors and CAPE subscales in relation to the COMTVal158Met genotype.
Total sample
mean (SD)
Val/Val
mean (SD)
Val/Met
mean (SD)
Met/Met
mean (SD) 𝐹 (𝑃)
Schizotypy (WSS)
Positive −0.46 (0.75) −0.44 (0.85) −0.48 (0.70) −0.45 (0.74) 0.244 (0.783)
Negative −0.04 (0.90) −0.06 (0.90) −0.01 (0.90) −0.06 (0.90) 0.634 (0.531)
Psychotic experiences (CAPE)
Positive 8.05 (4.85) 8.18 (4.84) 7.80 (4.78) 8.39 (5.01) 1.485 (0.227)
Negative 9.19 (5.26) 9.06 (4.96) 9.40 (5.45) 8.93 (5.24) 0.508 (0.602)
WSS, Wisconsin Schizotypy Scales; CAPE, Community Assessment of Psychic Experiences. Differences were considered significant if 𝑃 was below 0.05.
The COMT Val158Met polymorphism (rs4680, G>A)
was genotyped using TaqMan 5󸀠 exonuclease assay (Applied
Biosystems). The probe for genotyping the rs4680 was
ordered through the TaqMan SNP genotyping Assays (ID:
C 25746809 50) Applied Biosystems assay-on-demand ser-
vice. The final volume was 5 𝜇L, which contained 5 ng of
genomic DNA, 2.5 𝜇L of TaqMan Master Mix, and 0.25 𝜇L of
20 genotyping assay. Polymerase chain reaction plates were
read on an ABI PRISM 7900HT instrument and SDS v2.1
software (Applied Biosystems) was used for the genotype
analysis of data.
2.4. Statistical Analyses. Hardy-Weinberg equilibrium for
genotypic distribution was analysed using an online chi-
squared Hardy-Weinberg equilibrium test calculator for
biallelicmarkers (http://www.oege.org/software/hwe-mr-calc
.shtml) [42].
All data were processed using SPSS 20.0 software.
ANCOVA (analysis of covariance) was performed to test
the effect of COMT Val158Met genotype (Val/Val, Val/Met,
and Met/Met) on the positive and negative schizotypy and
PEs scores. We also used ANCOVA to study the interaction
between sex and COMT genotype on positive and negative
schizotypy and PEs. The analyses were repeated comparing
subjects who were carriers of at least one Val allele (Val
carriers: Val/Val and Val/Met genotypes) versus Met/Met
subjects.
3. Results
The total sample comprised 808 subjects. Differences were
observed between the undergraduate and the technical
school students in relation to age and sex. Also, the positive
and negative schizotypy scores and the positive PEs scores
were higher in the technical school sample than in the
undergraduate student sample. See Table 1 for more details
on the two groups. All the analyses were corrected by sex,
age, and also considering whether individuals were from
the university student sample or from the technical training
school sample.
Of the whole sample, 805 individuals agreed on providing
a DNA sample. COMT genotyping failed for 31 individuals.
The two alleles Val and Met were present at overall frequen-
cies of 52.8% and 47.2%, respectively. The three genotypes
were Val/Val 28.7% (223/777), Val/Met 48.1% (374/777), and
Met/Met 23.2% (180/777). The genotypes were in Hardy-
Weinberg equilibrium. Both genotypic and allelic frequencies
observed in our sample are in accordance with those found in
other European populations and previous studies [30]. Mean
scores and standard deviations of the WSS factors and CAPE
subscales for the whole sample, as well as by genotype, are
shown in Table 2.
The association of positive and negative schizotypy
with the Val158Met genotype was not significant (positive
schizotypy: 𝐹 = 0.244, 𝑃 = 0.783; negative schizotypy:
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𝐹 = 0.634, 𝑃 = 0.531; see Table 2). The lack of associ-
ation held when analyses were conducted in the sample of
males and females independently (data not shown). Two-
way ANCOVA analyses (genotype∗sex) were conducted
separately for positive and negative schizotypy. A significant
interaction was found between COMT genotypes (Val/Val,
Val/Met, and Met/Met genotypes) and sex with regard to
negative schizotypy (𝐹
(2,772)
= 3.924, 𝑃 = 0.020). No
significant interaction was found for positive schizotypy
(𝐹
(2,772)
= 0.232, 𝑃 = 0.793).
The association between the two subscales of the CAPE
and theVal158Met genotypewas not significant (positive PEs:
𝐹 = 1.485, 𝑃 = 0.227; negative PEs: 𝐹 = 0.508, 𝑃 = 0.602;
see Table 2). When analyses were conducted in males and
females independently, a significant association was found
in males with regard to negative PEs. Specifically, subjects
with theVal/Met genotype showed higher scores thanVal/Val
and Met/Met subjects (𝐹 = 3.591, 𝑃 = 0.030). Two-way
ANCOVA analyses (genotype∗sex) were conducted sepa-
rately for positive and negative PEs. A significant interaction
was detected between the three COMT genotypes and sex
with regard to negative PEs (𝐹
(2,772)
= 4.229, 𝑃 = 0.015).
No significant interaction was detected with positive PEs
(𝐹
(2,775)
= 0.152, 𝑃 = 0.859).
Further analyses grouping the COMT genotypes in Val
carriers (Val/Val and Val/Met) and Met/Met revealed that
these significant interactions resultedmostly from significant
effects of the COMT Val allele in males. Males carrying Val
alleles showed significantly higher scores for the negative
dimension of both schizotypy (negative schizotypy: 𝐹
(1,772)
=
5.127, 𝑃 = 0.024; see Figure 1(a)) and PEs (negative PEs:
𝐹
(1,772)
= 8.282, 𝑃 = 0.004; see Figure 1(b)). Females, in
contrast, did not show this pattern (Figure 1).
4. Discussion
In the current study we tested the hypothesis that the
functional polymorphism Val158Met in the COMT gene
would be associated with the negative dimension of the
psychosis proneness phenotype in a nonclinical sample. Such
phenotypes often referred to as “intermediate phenotypes”
or endophenotypes with which schizophrenia presumably
shares a degree of overlapping genetic liability are useful in
studying the potential effect of candidate susceptibility genes
for the disorder. Our main finding is that sex modulated the
association between the COMT genotype and the negative
dimension of both schizotypy and PEs.
These findings contribute to the growing literature on
sex-specific effects of the role of COMT in the vulnerability
to psychiatric or cognitive phenotypes and personality traits
[10, 43–45]. In the present study, male subjects carrying the
Val allele tended to score higher on the negative dimension
of both trait and symptom-like measures. Our results are
consistent with several studies that have investigated, at
the population level, schizotypal traits as phenotypes in
relation to the COMT in samples of young men [29–31].
In other nonclinical studies, although hypotheses regarding
sex-specific associations were not specifically addressed,
a trend towards a specific association in males was also
detected [32, 46]. The association between COMT and
CAPE scores has only been examined in studies of gene-
environment interaction. In this regard, recent studies have
shown that COMT constitutes a genetic risk factor for PEs in
the context of combined exposure to childhoodmaltreatment
and/or cannabis use [47–50]. However, the neurobiological
bases of this interaction remain poorly understood.
The role of COMT in schizophrenia has been extensively
studied and it seems that neither genetic variants nor the
catalytic activity of the enzyme has great intrinsic influence
on schizophrenia risk. However, multiple lines of evidence
indicate that the high-activity COMT Val allele is associated
with greater severity of negative and cognitive symptoms in
schizophrenia, as well as specific endophenotypic impair-
ments related to prefrontal deficits such as schizotypal traits
[51]. In this regard, neuroimaging studies seem to point out
the importance of low dopaminergic activity in the prefrontal
cortex of schizophrenia patients. Specifically, the COMT
Val carriers, with high enzyme activity, may have reduced
dopamine levels in several brain regions and specifically in
the prefrontal cortex, leading to a decrease in D1 receptors
activation with subsequent impairment in cognitive tasks,
such as workingmemory, as described in patients and healthy
individuals [52]. The neurobiological mechanism underlying
this association is highly debated and emerging findings from
animalmodels seem to suggest that the significance of COMT
for dopamine regulation is not limited to the prefrontal cortex
[53].
The sex-specific association of the COMT gene with the
negative dimension of psychosis proneness described here
is in line with several studies in schizophrenia (reviewed by
Godar and Bortolato [54]). In this regard, it seems that the
effect of the Val158Met polymorphism on schizophrenia vul-
nerability is more directly related to male patients, possibly
through an epistatic interaction with D1 receptors [15].
Higher COMT activity in the prefrontal cortex in men
occurs despite a similar expression of the genes (i.e., mRNA
and proteins) in both sexes. This dissociation between
expression and activity may be explained by the ability
of testosterone to increase COMT activity or the effect of
estrogens. In this respect, it seems that there is a reciprocal
COMT-estrogen modulation by which the COMT genotype
influences the role that estrogens play in the brain, while
estrogens affect COMT activity and its pathophysiological
phenotype. An additional mechanism that may predict a
lower COMT activity in females may be afforded by the
function of catechol-estrogens and its role modulating the
turnover of catecholamines. Further evidence on sexual
dimorphic effects of this gene is provided byCOMTknockout
mouse studies. They provide evidence for an important sex-
and region-specific contribution of COMT in the mainte-
nance of steady-state levels of catecholamines in the brain and
suggest a role for COMT in some aspects of emotional and
social behaviour in mice [55].
The finding of an association between the COMT poly-
morphism and the negative dimension of the psychosis
proneness phenotype provides evidence that the biological
effects of the COMT gene may be relevant to the patho-
physiology of schizophrenia. The balance of dopamine in
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Figure 1: Mean scores of the psychosis proneness variables by sex and genotype (Val carriers versus Met/Met). (a) Positive and negative
schizotypy and (b) positive and negative psychotic experiences.
prefrontal and striatal regions might be related to schizoty-
pal characteristics evident in individuals who carry genetic
liability for the condition. COMT gene is only a part of
the complex neural dopaminergic system. Other dopamine
genes and receptors and possibly other systems such as
the serotoninergic system may all interact with the effects
of this gene. The current evidence on the implication of
other dopaminergic targets in gene-sex interactions is scant
and mostly limited to dopaminergic receptors. Interestingly,
several studies have shown that polymorphic variants in D1,
D2, and D4 receptors are linked to different responses to
antipsychotic medication in a gender-sensitive fashion.
The findings of this and previous studies seem to indicate
that the role of gene∗sex interactions might affect brain
substrates through different mechanisms with a particular
impact on the catabolic action on dopamine. A compre-
hensive understanding of the genetic basis of schizotypy
needs to consider the contributions of multiple genes and
also environmental and biological factors. In this regard, the
integration of preclinical research with neuroimaging and
genetic studies will play a critical role enabling us to identify
central neurobiological networks that underpin sex-specific,
neurobehavioral endophenotypes of schizophrenia.
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